A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration

被引:646
作者
Hodgson, JG
Agopyan, N
Gutekunst, CA
Leavitt, BR
LePiane, F
Singaraja, R
Smith, DJ
Bissada, N
McCutcheon, K
Nasir, J
Jamot, L
Li, XJ
Stevens, ME
Rosemond, E
Roder, JC
Phillips, AG
Rubin, EM
Hersch, SM
Hayden, MR [1 ]
机构
[1] Univ British Columbia, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada
[2] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada
[3] Univ Toronto, Fac Pharm, Toronto, ON L4V 1V7, Canada
[4] Univ Toronto, Dept Mol Immunol & Neurobiol, Toronto, ON M5G 1X5, Canada
[5] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[6] Univ Calif Berkeley, Lawrence Berkeley Lab, Ctr Human Genome, Berkeley, CA 94720 USA
关键词
D O I
10.1016/S0896-6273(00)80764-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We have produced yeast artificial chromosome (YAC) transgenic mice expressing normal (YAC18) and mutant (YAC46 and YAC72) huntingtin (htt) in a developmental and tissue-specific manner identical to that observed in Huntington's disease (HD). YAC46 and YAC72 mice show early electrophysiological abnormalities, indicating cytoplasmic dysfunction prior to observed nuclear inclusions or neurodegeneration. By 12 months of age, YAC72 mice have a selective degeneration of medium spiny neurons in the lateral striatum associated with the translocation of N-terminal htt fragments to the nucleus. Neurodegeneration can be present in the absence of macro- or microaggregates, clearly showing that aggregates are not essential to initiation of neuronal death. These mice demonstrate that initial neuronal cytoplasmic toxicity is followed by cleavage of htt, nuclear translocation of htt N-terminal fragments, and selective neurodegeneration.
引用
收藏
页码:181 / 192
页数:12
相关论文
共 46 条
  • [1] ALTERNATIVE EXCITOTOXIC HYPOTHESES
    ALBIN, RL
    GREENAMYRE, JT
    [J]. NEUROLOGY, 1992, 42 (04) : 733 - 738
  • [2] [Anonymous], 1991, HUNTINGTONS DIS
  • [3] DIFFERENTIAL SPARING OF SOMATOSTATIN-NEUROPEPTIDE-Y AND CHOLINERGIC NEURONS FOLLOWING STRIATAL EXCITOTOXIN LESIONS
    BEAL, MF
    KOWALL, NW
    SWARTZ, KJ
    FERRANTE, RJ
    MARTIN, JB
    [J]. SYNAPSE, 1989, 3 (01) : 38 - 47
  • [4] Dentatorubral and pallidoluysian atrophy (DRPLA) - Clinical and neuropathological findings in genetically confirmed North American and European pedigrees
    Becher, MW
    Rubinsztein, DC
    Leggo, J
    Wagster, MV
    Stine, OC
    Ranen, NG
    Franz, ML
    Abbott, MH
    Sherr, M
    MacMillan, JC
    Barron, L
    Porteous, M
    Harper, PS
    Ross, CA
    [J]. MOVEMENT DISORDERS, 1997, 12 (04) : 519 - 530
  • [5] Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment
    Buxbaum, JD
    Choi, EK
    Luo, YX
    Lilliehook, C
    Crowley, AC
    Merriam, DE
    Wasco, W
    [J]. NATURE MEDICINE, 1998, 4 (10) : 1177 - 1181
  • [6] Subtype-specific enhancement of NMDA receptor currents by mutant Huntingtin
    Chen, NS
    Luo, T
    Wellington, C
    Metzler, M
    McCutcheon, K
    Hayden, MR
    Raymond, LA
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (05) : 1890 - 1898
  • [7] COHEN J, 1995, NEURAL CELL CULTURE
  • [8] Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture
    Cooper, JK
    Schilling, G
    Peters, MF
    Herring, WJ
    Sharp, AH
    Kaminsky, Z
    Masone, J
    Khan, FA
    Delanoy, M
    Borchelt, DR
    Dawson, VL
    Dawson, TM
    Ross, CA
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (05) : 783 - 790
  • [9] COYLE JT, 1993, ANN NEUROL, V38, P357
  • [10] Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
    Davies, SW
    Turmaine, M
    Cozens, BA
    DiFiglia, M
    Sharp, AH
    Ross, CA
    Scherzinger, E
    Wanker, EE
    Mangiarini, L
    Bates, GP
    [J]. CELL, 1997, 90 (03) : 537 - 548